Semaglutide Weight Loss in Maine and New Hampshire

Semaglutide is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves insulin signaling. Originally developed for type 2 diabetes, it has become one of the most clinically studied tools for sustained weight loss. At Med Matrix, semaglutide is prescribed as part of a broader protocol that includes lab work and lifestyle support, not as a standalone medication.

Before prescribing semaglutide, we run a 100-biomarker blood panel to identify what is driving your weight gain. Thyroid dysfunction, insulin resistance, hormonal imbalances, and chronic inflammation all contribute to stubborn weight. We address those root causes alongside the GLP-1 therapy so that results hold long term, not just while you are on the medication.

Full onboarding runs approximately $1,200 to $1,500 all-in, covering your 100-biomarker lab panel, InBody 770 body composition scan, provider prep time, and a full one-hour provider consultation. Semaglutide medication costs vary depending on your protocol. New patients receive a $100 voucher toward their first visit. We accept HSA and FSA accounts.

The most common side effects are nausea, mild digestive discomfort, and reduced appetite, especially in the first few weeks as your dose increases. Most patients tolerate the medication well when titrated gradually. Your provider monitors your labs and adjusts your protocol as needed throughout your program.

Semaglutide is appropriate for adults who have struggled to lose weight through diet and exercise alone, particularly those with insulin resistance, metabolic syndrome, or a BMI over 27 with a related health condition. During your first visit, your provider reviews your full lab panel and health history to determine whether semaglutide fits your goals and your biology.

Both are GLP-1 receptor agonists that reduce appetite and support weight loss. Tirzepatide also targets a second receptor (GIP), which may produce slightly greater weight loss in some patients. At Med Matrix, your provider reviews your full lab panel, metabolic markers, and health history to determine which medication fits your biology. The right choice depends on your individual results, not a generic recommendation.

Most patients notice reduced appetite and less food noise within the first two to four weeks. Measurable weight loss typically begins within the first month, with steady progress over three to six months as your dose is gradually increased. Your provider tracks your body composition with InBody scans at each visit, so you can see changes in fat mass and muscle mass separately, not just the number on the scale.

Yes. Semaglutide is FDA-approved for weight management in adults without diabetes. At Med Matrix, we prescribe it for patients with a BMI over 27 who have a weight-related health condition, or a BMI over 30. Your provider confirms eligibility based on your lab results and health history during your first visit.